EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Cancer‐Specific RNA Modifications in Tumour‐Derived Extracellular Vesicles Promote Tumour Growth

Yuya Monoe iD, Kentaro Jingushi, Kohei Taniguchi, Kensuke Hirosuna, Jun Arima, Yosuke Inomata, Yoshiaki Takano, Hiroki Hamamoto, Kazumasa Komura, Tomohito Tanaka, Hiroaki Hase, Sang-Woong Lee and 1 more

Journal of Extracellular Vesicles · 2025

DOI: 10.1002/jev2.70083 ↗

At a glance

Journal article in Journal of Extracellular Vesicles, 2025. Written by Yuya Monoe and 12 co-authors. Institution: Laboratory of Molecular and Cellular Physiology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan. Major MEDLINE topics: Extracellular Vesicles, Colorectal Neoplasms, RNA Processing, Post-Transcriptional. Cited 13 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY 4.0). Funded by: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

RNA modifications are crucial in cellular processes, and their dysregulation is linked to diseases like cancer. Extracellular vesicles (EVs) contain various RNAs and might be susceptible to modifications, but detecting these modifications has been challenging due to the small amount of RNA in EVs. We successfully detected 22 RNA modifications in EVs using a proprietary ultra‐HPLC MS/MS system. We identified reduced levels of N6‐methyladenosine (m6A) in EVs derived from colon cancer tissues, which correlated with cancer recurrence. Increasing m6A levels via m6A demethylase Alkbh5 knockout suppressed the tumour‐promoting effects of colorectal cancer EVs. Mechanistically, colorectal cancer‐derived EVs increased tumour necrotic factor α and interleukin‐6 secretion by macrophages via Toll‐like receptor 8 in an m6A‐dependent manner, promoting cancer cell proliferation. RNA‐sequencing analysis showed that the levels of 5′‐half‐tRNA fragment (5′‐half)‐GlyGCC as well as those of m6A‐modified 5′‐half‐GlyGCC were higher and lower, respectively, in colorectal cancer EVs than in normal colon tissue EVs. Cancer‐derived EVs containing 5′‐half‐GlyGCC significantly promoted tumour growth, which was impeded by macrophage depletion. These findings provide evidence that cancer‐specific RNA modifications are present in EVs, promoting tumour progression by regulating immune cells.

Subjects

MeSH terms (MEDLINE)

Extracellular VesiclesColorectal NeoplasmsRNA Processing, Post-TranscriptionalHumansAnimalsMiceCell ProliferationAdenosineCell Line, TumorAlkB Homolog 5, RNA DemethylaseFemaleMaleMacrophages

Author keywords

5′‐half‐GlyGCCRNA modificationcolorectal cancerextracellular vesiclesinflammatory cytokines

Substances

N-methyladenosineAdenosineAlkB Homolog 5, RNA DemethylaseALKBH5 protein, human

Authors and institutions

  • Laboratory of Molecular and Cellular Physiology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, Japan.
  • Center for Medical Research & Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
  • Department of Regenerative Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.

ORCID profiles: Yuya Monoe

Funding

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development

Cite

APA

Monoe, Y., Jingushi, K., Taniguchi, K., Hirosuna, K., Arima, J., Inomata, Y., Takano, Y., Hamamoto, H., Komura, K., Tanaka, T., Hase, H., Lee, S. W., & Tsujikawa, K. (2025). Cancer‐Specific RNA Modifications in Tumour‐Derived Extracellular Vesicles Promote Tumour Growth. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70083

Vancouver

Monoe Y, Jingushi K, Taniguchi K, Hirosuna K, Arima J, Inomata Y, et al. Cancer‐Specific RNA Modifications in Tumour‐Derived Extracellular Vesicles Promote Tumour Growth. Journal of Extracellular Vesicles. 2025. doi:10.1002/jev2.70083

BibTeX
@article{Monoe2025,
  author = {Monoe, Yuya and Jingushi, Kentaro and Taniguchi, Kohei and Hirosuna, Kensuke and Arima, Jun and Inomata, Yosuke and Takano, Yoshiaki and Hamamoto, Hiroki and Komura, Kazumasa and Tanaka, Tomohito and Hase, Hiroaki and Lee, Sang-Woong and Tsujikawa, Kazutake},
  title = {Cancer‐Specific RNA Modifications in Tumour‐Derived Extracellular Vesicles Promote Tumour Growth},
  journal = {Journal of Extracellular Vesicles},
  year = {2025},
  doi = {10.1002/jev2.70083}
}
Start for free →